Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...
Stockhead on MSN
Health Check: It’s shake-up time at the top amid a string of executive and board changes
Integrated Diagnostics and Medadvisor have new CEOs, while the elsewhere the boardroom revolving door is spinning furiously.
5don MSN
Seattle startup Accipiter Bio emerges with $12.7M and big pharma deals for AI-designed proteins
A Seattle biotech startup born from a Nobel laureate's lab has landed $12.7 million and partnerships with pharmaceutical ...
Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue ...
Nvidia is the most valuable company in the world, and it's not cheap. It trades at a P/E ratio of 53 and a price-to-sales ...
In January 2019, Locus entered a collaboration with Janssen Pharmaceuticals, one of Johnson & Johnson's companies, to develop ...
During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...
Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...
Diageo appointed former Tesco boss Dave Lewis as its CEO on Monday, turning to an outsider to steer the world's largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results